Document x19E661OEqEd1O33wkrNwwMBE

CFFhConCCAootrroeemeTTyeeaaPrmvmelage22d 0004-W.02o2r00k40055PPPrrrooojjedeDcctuot n/coPPttrcrooo:pccyeessossrdPiPsrrtiirooirbriuittteiieess Client-Attorney Priveleged Work Product: Do not copy or distribute r00001] SRtreatemgy !RBiCYYe's [Sn ---- Command the science: exposure, sg to,sac, rn analytical, fate, effects, human health jinn and ecological Project & Processes Pls otto cpl rs nFdenies Develop and maintain internal 3M analytical capability- telomers and ECF chemistries Dev fg for resin ih spcto ots nd ECFchaste Develop strategy for external science with respect to telomers and ECF chemistries UnTdFA srssomatnwok Understand TFA risk assessrnent work Des nd ler Pl Pl:Rezet 9cs be ube coritod ge chr Fr hessch Develop and implement a 3M Publication Plan: Research to be published as completed in open scientific literature- health research Doris dilantin Fesenchls bbls copied pm sc Rt smfrmers Develop and implement a 3M Publication Plan: Research to be published as completed in open scientific literature- environmental. (CCrreeaattee aapprroocceessssttoottrraacckkgglloobbaallFFCCrerellaatteeddwwoorrkkoouutstsiiddeeooff33MM ((PPuubblliiccunuinvievresristitiieess., ggoovveerrnmmeenntt iinnssttiittuutteess,,etectc..i,inncclluuddiinngg lieterraattuurreeaanndd in) Devppress tomerscot Bsr orn ds ith espaciohs fc nd oer tes funding). Develop process to monitor scientific literature for new data with respect to health effects and environmental issues Hck drslpnt of baer by rr DeConos lCDC Track developments of biomonitorinq b~' Centers for Disease Control (CDC). sce hoki or pty kaosrs npdnelcr reps or Sie A, Por ie mesg If necessary, hold workshop for third pa~ spokespersons and include preparation for Science Advisory Panel public meetingsFeist Sit Adon Bou: of 1,3,o MSAD bs EPA PFOA ssn nd PES IRI proc Revisit 3M Scientific Advisor~ Board: Define role, if an>', of 3M SAB in the EPA PFOA risk assessrnent and PFO$ IRIS processes. Devs sey o presets E9ASAB on POA assent. nc misty ean Develop strategy to present to EPA SAB on PFOA risk assessment. Include industry team. [RReeesetsatablbilisshh iinntteerrnnaattiioonnaall rreegguullaattoorry~--sscciieennttiifficc--lleeggaalk-ppuubblliiccaaffffaaiirrssiinnffrraassttruuccttuurree--iiddeenniftiy~rreessoouurrcceess,,reresspopnosnisbiibliltitiieessaannddrerelalattiioonnsshhiippssttoo US Core Team US Core Team. Track agendas for, be aware of and participate in science and regulator'j conferences. Dorp sag bk her arson OUSsine pe ston thReScrc hLo Develop strategy/to build stronger (International) OUS science representation at the Research Science Level Develop strategy to build stronger (International) OUS science representation at the Science Policy Level Devlop fest oes tonite eo ndevanenanecnefs ppo oF POS PFOA. Develop and implement a program to understand the toxicology' and environmental mechanisms for support of the PFOS, PFOA, Rei hedogofshe pdm ot rd aos 0p Review the adequac~j of the epidemiology data and address an~/gaps. Ete PFO prcusor ncthr roucs,if Evaluate PFOA precursors in other products, if any. Review the adequacy' of the biomonitoring data and address an~' gaps. 19640001 1964.0001 Exhibit 1964 State of Minnesota v. 3M Co., Court File No. 27-CV-10-28862 Acespl posirs ot Achieve neutral to positive regulatory ney kms, ndssnd ti Doc Asinsty PEOSroto,opinbg st agency outcomes: findings and actions Develop an Asian strategy for PFOS regulation, Japan being first. Devon sinshtg oPOA ston Jpn beng fst Develop an Asian strategy for PFOA regulation, Japan being first. Devlo anEsfot BEDSe sicypoy Develop an EU strategy for PFOS science policy ovo EsforPt OAsiey npic Develop an EU strategy for PFOA science policy Esvoundeinsnd pop lk manet Er fog goa ihUC DEFRA RkRecSao Ensure sound science and appropriate risk management at EU level by staying engaged with UK-DEFRA Risk Reduction Strateqy (Conaa- FOSEnfomaa Aesmen: Creomeango lorswhEnna Coad vgh49d ora Canada- PFOS Environmental Assessment: Continue to maintain good relations with Environment Canada through regular contacts ind sstainn ssh oaancho Bose ron. scl and strive to ensure that the final assessment - and any actions based thereon- are accurate and fair. OECD: orinefomaaOECD for rte egy desman OECD: Continue to monitor OECD for further requlator~' developments. UntoiorsEnorPagtanne ONEP): Cortrusto ond UVEPScie or thor PEOSPFORwand United Nations Environmental Programme (UNEP): Continue to monitor UNEP activities for further PFOS/PFOA-related TskAci fSvenChlnpc,Enesidscr nd pce ok by saing sage Track Activities of Sweden Chemicals Inspectorate. Ensure sound science and appropriate risk management by staying engaged with RedisaofiItS oojossby mos torts alc hoes. Look eae cass (3, PCE') nd Review historical use of IRIS reviews by international, national, state and local authorities. Look at related cases (e.g. PCB's) and nk U5)oder nds nd eot s iey d FC. BrnigbA CAdc Monitor (US) federal and state legislative and regulatory activities related to FC's. Biomonitoring bill in CA, etc. rap snd sb ol patos : EPA ben 90marks : Prepare and submit final perfluorooctanyl phase-out summary to EPA when 3M inventories are substantially expired. Corer commas[t05t5Aybphoitvcantodbssehfne.ngbhonUndCpiioPlgEctsGpoShmlrtmhicdEmPsPaAO'rsAsOtRdDoa(cas0s.ePsyssornrdrbrooocdecasutnresatsgdeo)rtgr.anAcumei,pc5m.peorleysmca)gatedsrcehocrpgaiFss. sid | Satisfy C$ regulator~ commitments Establish and strengthen dialogue with EPA's ORD (Dr. Preuss) and management (C. Auer, S. Johnson) and other parties outside EPA who will be influential in PFOS and PFOA risk assessment processes and other science policy matters affecting FC's. IS political strategy: Update the political strategy document and key contacts listing and implement agreed plan. Satisfy 3M letter of Intent (LOb commitments Satisfy Dyneon letter of Intent (LOI) commitments oct fPlt ds SP)Vik cen i FIG30 PT compte ECRnegates ndrman LOIECA Society of Plastics Industry (SPI): Work successfully with FMG and SPI to complete ECA negotiations and implement LOI/ECA commen. commitments. Support saofPl assWo orfnn Ep (PVE ogy so sm 08 og Support Association of Plastics Manufacturers in Europe (APME) toxicology and environmental study programs. Set up internal management review for Decatur site monitoring issues. Set up internal management review for Gendorf site monitoring issues. a Set up internal management review for Cottage Grove site monitoring issues. [SH WOUPer3Sst orkang- FOR Satisfy MOU Process- 3M Site Monitorinq- PFOA a amet Gat Ta ~ntwerp groundwaterJsite assessment: Complete risk assessment. Cottage Grove-Drinking Water (MN Dept. of Health): Determine monitoring and process control requirements. SoDao rd setpas sat Complete 8(e) Self Disclosure and settlement Phase IV audit. 11996644.00000022 ngs sciogFC. MoMniontiotorraannddpprrioritiizeoeexxtrteerrnniaalltztreenneddss and organizations affecting FC's EfEfeffcetcitivveeccoommmumnuinciactaitioonn.. Moecor n sst con gt ofNGO'as nd pts. Monitor and understand future direction (globally) of NGO's and partnerships. r__________________________________________________] MMedediiaaaattetnetnitioonnttoo PPFFOOAARRisiskkAAsssesssmeensfJSsABmReReveivieneww.:tWWo/orrkSkwwiAithhBindustindusrtry yggrroouuppttoottaakkeetthheelleeaaddoonnddeeffeennssee ooff PPFFOOAAaannddsscciieennccee.. Maintain preparedness in order to respond to PFOA media coverage of risk assessment. Maintain talking points for ECNLOI and other US regulatory activities. MMaaintaiin 3n3MMtSSuusmmitiitoommnao talktialkingng ppoointisntsfoforr PPFFOOAA /SSAABB.. Develop a message testing mechanism for talking points- particularly in Europe Maintain talking points: C4 chemistry. Maintain talking points: 8(e) voluntary compliance audit. Maintain talking points: Decatur litigation. EE Assure FC Enterprise Risk EE vanities| Managgemeentment oorrggaannzaizioantaiolnal hheeaatlthh,. _|CoCnodnuducctt aarreessoouurrcceerreevviieeww((ccuurrrreennttaannddprporossppecetcitivvee)) ffoorroonnggooiinnggiissssuuee rnanagmange ement nneeeeddss.. EE -- C4 Regulatory and Product witty,| SStteewwaarrddsshhiipp SStrtraatteeggyy MMaaiinnttaainindialodialoggue uewwiitthh EEPPAAaannddiinntteernmaatioinoanl arelgulatoregulatos rsoonnCC4dchemischemtisrt y. [ccoonnsseennttoorrddeerrssaatttthheeeeaarrilieessttppoosssisbibllee ttiimmee.. I InclundeEcEPPAlA/NNuTTPPdclclaeassss ssttuuddyy acatcitviit~y.. [CCatlogatalogaalll ccurruentr33MMrCC4e4prponroddutucctt apappplilciactaioonnss.. PProrcesosaacnnddeccoonsnttrroosllppllaann nneeeeddeedd.. Continue phaseout trajectory (C8 use/emission/exposure reduction) [ReRveieiwtthhe adaeqduascyoqofftuthheeaCC4c4ppyool~ljmeer ddergraadiatnionddeattaaaanndaadrderesssaannyy ggaapps.s. Evaluate scenarios for full commercialization of PFBS (modelling project) Develop a reference dose for C4 to determine if environmental/biomonitoring need to be done. ee Impprrovoeve rreevvieiwepwprroocceessssooffaalll CC44ccoommmmereciraliczaitioanfleioffoztrtasitinn3i3MMn.. Prepare a summary of existing perfluorooctanyl inventories across 3M's business units and establish timetables for consumption or use of inventories. Review PFOS exposure assessments and related information. Develop strategy about monitoring of possible source areas, based on existing PFOS exposure assessments and modelling. 1964003 1964.0003